about
Zinc Selectively Blocks Neurosteroid-Sensitive Extrasynaptic δGABAA Receptors in the Hippocampus.Sex differences in the anticonvulsant activity of neurosteroidsNeurosteroids Involvement in the Epigenetic Control of Memory Formation and Storage.Neurosteroids for the potential protection of humans against organophosphate toxicity.Do oral contraceptives increase epileptic seizures?Glycolysis Inhibition: The Gift of GAB(A)Decreased surface expression of the δ subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome.TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis.Epilepsy Treatment: A Futurist View.Mapping Two Neurosteroid Modulatory Sites in the Prototypic Pentameric Ligand Gated Ion Channel GLIC.Catamenial-like seizure exacerbation in mice with targeted ablation of extrasynaptic δGABA-a receptors in the brain.PR-independent neurosteroid regulation of α2-GABA-A receptors in the hippocampus subfields.Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy.Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation.Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.The anxiolytic-like effects of ginsenoside Rg3 on chronic unpredictable stress in rats.Androgen Regulation of the Mesocorticolimbic System and Executive Function.Fragile X syndrome
P2860
Q37147577-1AA3B97C-AE6C-49A1-8AA0-E8C88D12AD53Q37432122-87BB1302-083F-44E9-BC2A-3945988DCE2BQ37549551-BD9D983B-B6FB-4D3E-96FD-EC0D4D7098AAQ38906587-CB86A928-26DB-4D95-8588-7F3B59ED07DFQ39333859-25D7887D-D478-42C6-BAEF-93DB414643AFQ42084996-9C0E9A31-3101-48F0-8855-364FBFC92EEEQ45011378-F765CBA6-FBB6-4EF5-9A92-2BF69C7298F5Q46330298-AB922AA7-BBEE-41FF-BA55-468C71C26473Q47114432-7B26699D-E194-45D4-A13F-43EA5699334FQ47215360-6B2B69A5-BB73-408E-B774-F58F880BE873Q47848096-F6B4DA95-7839-4385-B428-78E7DD5D07CEQ47875905-D46A966E-8211-485F-934B-826089CC4F57Q47967839-3C38F243-9960-4017-BE30-3B7EF890EFD6Q48126920-D5A7B2B8-CEC8-4F7E-A576-5A9DE8E331B1Q52641631-67E98BEE-9FBC-4505-8EAC-490F853273ACQ55264954-76DEE1B7-3545-40BB-87B6-2FAF22ED7DF6Q55344917-09914E36-6BC3-4341-A14B-030B51193895Q57828399-189280D9-A4D5-4834-8937-1101CC7AD09C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical Potential of Neurosteroids for CNS Disorders.
@en
Clinical Potential of Neurosteroids for CNS Disorders.
@nl
type
label
Clinical Potential of Neurosteroids for CNS Disorders.
@en
Clinical Potential of Neurosteroids for CNS Disorders.
@nl
prefLabel
Clinical Potential of Neurosteroids for CNS Disorders.
@en
Clinical Potential of Neurosteroids for CNS Disorders.
@nl
P2860
P1476
Clinical Potential of Neurosteroids for CNS Disorders
@en
P2093
William A Estes
P2860
P304
P356
10.1016/J.TIPS.2016.04.003
P50
P577
2016-05-05T00:00:00Z